Maria J. Puchades

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Effect of IV ferric carboxymaltose treatment on platelet counts and serum transferrin levels in CKD patients not on dialysis with iron deficiency: potential implications for thrombogenicity.

Effect of IV ferric carboxymaltose treatment on platelet counts and serum transferrin levels in CKD patients not on dialysis with iron deficiency: potential implications for thrombogenicity.

Journal: Renal failure

Published: March 30, 2026

Position statement of the SEN Anemia Working Group: A critical and contextualized adaptation of the KDIGO 2026 anemia guidelines to the Spanish setting.

Position statement of the SEN Anemia Working Group: A critical and contextualized adaptation of the KDIGO 2026 anemia guidelines to the Spanish setting.

Journal: Nefrologia

Published: March 02, 2026

Chloride at the spotlight-but not alone: towards a multi-ionic diuretic strategy.

Chloride at the spotlight-but not alone: towards a multi-ionic diuretic strategy.

Journal: Clinical kidney journal

Published: December 28, 2025

Randomized clinical trials: role of the research nurse.

Randomized clinical trials: role of the research nurse.

Journal: Journal of nephrology

Published: December 27, 2025

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 22, 2025

Analysis of the carbon footprint of pharmacological treatments in advanced chronic kidney disease and peritoneal dialysis: Oral vs. subcutaneous administration.

Analysis of the carbon footprint of pharmacological treatments in advanced chronic kidney disease and peritoneal dialysis: Oral vs. subcutaneous administration.

Journal: Nefrologia

Published: November 26, 2025

Real-world use of patiromer in patients with hyperkalaemia: A retrospective study from the Valencian Community.

Real-world use of patiromer in patients with hyperkalaemia: A retrospective study from the Valencian Community.

Journal: Nefrologia

Published: July 16, 2025

Impact of intravenous ferric carboxymaltose on physical performance and patient-reported outcomes in elderly patients with non-dialysis CKD, mild anemia, and iron deficiency: A pilot study.

Impact of intravenous ferric carboxymaltose on physical performance and patient-reported outcomes in elderly patients with non-dialysis CKD, mild anemia, and iron deficiency: A pilot study.

Journal: Nefrologia

Published: July 04, 2025

Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU.

Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU.

Journal: Revista espanola de cardiologia (English ed.)

Published: June 02, 2025

Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology.

Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology.

Journal: Nefrologia

Published: October 20, 2024

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial.

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial.

Journal: Nature medicine

Published: September 03, 2024

Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post-hoc analysis of the ROTATE-3 study.

Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post-hoc analysis of the ROTATE-3 study.

Journal: Diabetes, obesity & metabolism

Published: June 05, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026